Skip to main content

Table 4 Cost-effectiveness, Societal Perspective

From: Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists

Strategy Mean Costs, $ Mean Effects, QALMs Incremental Costs, $ Incremental Effects, QALMs ICER, $/QALM gained
Community pharmacist-initiated 78.70 (54.27; 108.25) 0.75232 (0.51506; 0.92437)
Family physician-initiated 239.43 (162.36; 327.39) 0.75236 (0.51555; 0.92461) 161.09 (80.29; 255.07) 0.00004 (−0.00685; 0.00709) 4,027,250
Emergency physician-initiated 609.78 (382.65; 894.90) 0.75239 (0.51676; 0.93418) Extended dominance
  1. Sequential analysis